A detailed history of Corton Capital Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, Corton Capital Inc. holds 12,604 shares of LUNG stock, worth $77,514. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,604
Previous 13,779 8.53%
Holding current value
$77,514
Previous $87,000 19.54%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.59 - $8.58 $6,568 - $10,081
-1,175 Reduced 8.53%
12,604 $104,000
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $79,504 - $135,309
13,779 New
13,779 $87,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $229M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.